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P
rotein translocation from the cyto-
sol into the endoplasmic reticulum 
(ER) is generally considered a rea-
sonably well understood, automatic pro-
cess. But getting proteins into the ER is 
actually a highly regulated process that 
poses more of a conundrum for the cell 
than it seems, especially under challenging 
metabolic conditions like ER stress (1). 
What’s more, aberrant or incomplete pro-
tein translocation can give rise to disease—
which Ramanujan Hegde has shown can 
happen with prion protein (PrP) (2, 3).
Throughout his career, Hegde has 
worked through the puzzle of protein 
translocation. His laboratory at the Na-
tional Institutes of Health focuses on try-
ing to understand how cells regulate pro-
tein translocation (4, 5) and how certain 
proteins like PrP can illuminate these 
enigmas, bringing new insights to normal 
processes (1) and to the development of 
prion disease (3). In a recent interview, 
we asked Hegde how he thinks through 
these problems and how he’s approached 
a career in research.
A GOOD FIT
Did you have any role models growing up?
My parents were both strong role models 
for me. My father’s family comes from a 
small village in rural India, and they are 
all farmers. But my father 
injured his foot when he 
was very young and couldn’t 
work in the fi   elds, so his 
only option was to study—
that’s how he got interested 
in mathematics. He was 
self-taught at fi  rst, but even-
tually he went to a local col-
lege, and then my family 
emigrated to Saskatoon, 
Canada when I was about 
six years old so that he could pursue a 
PhD there. A couple of years later, we 
moved to DeKalb, Illinois.
It took a lot of internal drive to get him 
where he is today, which is one of the things 
I’ve always really admired about him. My 
mother, too, has that kind of drive, although 
she put aside a lot of her interests and edu-
cation until her kids were grown up. She 
was a homemaker until my brother and I 
were about high school age, then she got a 
Bachelor’s degree at the college in DeKalb 
and pursued a career in computer science. I 
think the fact that both my parents hold 
education so central to their lives, and also 
that it was central to our immigration to the 
West, was very inspirational for me. I feel 
that I have a special set of opportunities 
that I might not otherwise have had, so I try 
my best to take advantage of that.
With that background, were you pretty 
much predestined to go to college?
Yeah. I’d thought about majoring in phys-
ics or astrophysics because I loved star-
gazing as a kid in DeKalb. But when I got 
to college at the University of Chicago, I 
majored in biology, in part because I felt I 
was “supposed” to go to medical school—
many fi  rst-generation immigrants seem to 
dream that their kids will become doctors. 
It’s weird—I actually thought biology 
was pretty boring, mostly because of the 
way it was taught. It was just a bunch of 
things to memorize that really had very 
little to do with problem solving, which 
was what I really enjoyed.
The summer after my 
fi  rst year of college, I worked 
in an insurance company do-
ing data entry, and that was 
by far the most boring, hor-
rible job I’ve ever had. That’s 
when I decided I really had 
to fi  nd something more in-
teresting to do. So I basically 
knocked on doors randomly 
and said I’d be happy to work 
in the laboratory. Clive Pal-
frey had space in his laboratory and took me 
on. That experience was really a key point 
in my career because that’s where I realized 
what doing biology was actually about. I 
started to see that it was really all about 
problem solving: breaking a very compli-
cated problem into smaller pieces, that then 
get approached and attacked in very specifi  c 
ways. Then, when you learn more about 
why people are studying a particular prob-
lem, it becomes much more interesting.
A PRETTY PUZZLE
But you still went on to medical school, 
didn’t you?
I entered an MD-PhD program at the Uni-
versity of California, San Francisco and 
started taking medical school classes. But 
within a month, I realized that, while the 
subject matter in medical school is very 
interesting, the mode of teaching isn’t 
problem solving–based. I decided I really 
missed the laboratory, and eventually I 
found a faculty member, Vishwanath Lin-
gappa, who didn’t mind having a med stu-
dent in his laboratory. I soon got so 
wrapped up in my research with Vishu 
that I stopped attending classes—I would 
just show up for the exams.
Was it the problems the laboratory was 
working on, or research itself, that 
drew you in?
When I started, I had no idea what Vishu 
worked on, and to tell you the truth, I 
don’t think it was especially important to 
me. I just wanted to be in the laboratory 
doing experiments. Slowly I learned that 
the area he was working on was how pro-
teins get either translocated into the ER 
Hegde uses prion protein as a model to explore how cells handle protein 
translocation and trafﬁ  cking.
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lumen or inserted into the ER membrane. 
Vishu wanted to understand how this 
process was regulated and how defects in 
these problems could lead to disease. He 
was ahead of his time, though, because 
people then were still trying to identify 
the core components of translocation.
One of Vishu’s early observations was 
that a small proportion of PrP, instead of 
being translocated completely across the 
membrane into the lumen of the ER, ei-
ther winds up getting released into the 
cytosol or gets inserted into the ER mem-
brane as a transmembrane form of the 
protein. I found this interesting, but be-
cause this observation was made in an in 
vitro translocation system, it seemed like 
an artifact to everyone else. In fact, my 
graduate committee rejected it when I 
proposed to study it as my thesis project!
From that I learned that you have to 
present a compelling case for something 
you want to study; you have to demon-
strate the relevance of it before you start 
investigating the molecular details. So 
what I wound up doing during my gradu-
ate work was to determine if this trans-
membrane form was relevant to anything. 
We turned to transgenic mouse studies 
and showed that mice with higher levels 
of this transmembrane form of PrP suf-
fered neurodegeneration.
THE NEXT PIECE
You took some of these same problems 
with you straight into your own 
laboratory…
I went ahead and fi  nished medical school, 
but it wasn’t a diffi  cult decision for me to 
pursue research full time. I was fortunate 
to be chosen for the National Cancer In-
stitute’s Scholar program, which basically 
meant I skipped doing a postdoc and set 
up a laboratory right away.
In the beginning, we started working 
on what I had proposed to 
do for my qualifying ex-
ams: trying to understand at 
a more molecular level how 
prion protein translocation 
is regulated, what parame-
ters infl  uence how effi  cient-
ly it is translocated into the 
ER, and how this trans-
membrane form (that’s as-
sociated with disease) gets 
made. Since then, we’ve expanded our in-
terests to other areas of protein transloca-
tion that we’ve slowly come to realize are 
very poorly understood.
How is protein translocation tied to 
things like ER stress?
Probably every process in the cell is regu-
lated. The trick is to try to think of condi-
tions where regulation of a particular proc-
ess would be advantageous to the cell. With 
respect to protein translocation into the ER, 
we realized fairly early on that one condi-
tion in which the cell would want to control 
the subset of proteins that are allowed to en-
ter the ER would be when the environment 
in the ER is less than optimal. 
This can happen when the ER 
is overburdened with proteins 
that need to be folded, or with 
certain toxic insults to the cell.
Prion protein translocation 
turned out to be regulated dur-
ing such stresses, probably be-
cause it’s a fairly diffi  cult pro-
tein to fold and because its 
misfolding can really cause 
problems for the cell in terms 
of aggregation. So we’re con-
tinuing to study how protein 
translocation might be regulated in a gen-
eral sense, using prion protein as a model to 
try to understand what determines whether 
or not a protein is translocated. Protein 
translocation could be regulated at the level 
of the translocation machinery (the translo-
con), in combination with differences in 
intrinsic protein features like signal se-
quences. These processes have been very 
challenging to understand, in part because 
they’re all happening at a membrane.
With respect to prion biology, it was very 
illuminating to us when 
we realized that mislocal-
ization of very small 
amounts of prion protein, 
and probably of other 
proteins as well, to the 
wrong part of the cell can 
be very detrimental. This 
might be because when 
proteins wind up in the 
wrong place, they can in-
teract with various factors that they would 
never normally see. So that raised the ques-
tion: how does the cell recognize and deal 
with mislocalized proteins? It’s possible 
that defects in these pathways could contrib-
ute to certain diseases of protein misfolding 
and neurodegeneration—so that’s some-
thing we’re interested in following up on.
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Hegde spotted the comet Hale-Bopp at perihelion while 
stargazing on his birthday.
Mislocalized proteins (wrench) can interfere 
with unrelated cellular machinery (gears).
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“Mislocalization 
of very small 
amounts of 
prion protein…
can be very 
detrimental.”